A study presented at the CHEST Annual Meeting showcased the safety and effectiveness of robotic-assisted bronchoscopy in targeting small and peripheral lung lesions. Conducted across 21 sites, the study included 679 patients with lung lesions, with a median size of 18.5 mm. The technology demonstrated robust diagnostic yield, particularly for cancer detection, with 65.7% of patients diagnosed with cancer at 12 months. Adverse events were minimal, with only 3.8% of patients experiencing complications related to the procedure. Overall, the study concluded that robotic-assisted bronchoscopy is a safe and effective tool for diagnosing and treating lung lesions across diverse patient populations.
Source link
Robotic-assisted bronchoscopy safe in targeting small, peripheral lesions
